This Multiple Myeloma Awareness Month, Dr Brid Seoighe, medical director at Johnson & Johnson Innovative Medicine Ireland, ...
Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today publication online in Scientific Reports -- Nature, of collaborative studies with Duke ...
The HealthTree Cure Hub registry: A patient-centered, multicenter approach to advancing multiple myeloma care. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
Atrial fibrillation (AF) is a relatively frequent complication after autologous stem cell transplantation in patients with multiple myeloma, one that’s associated with an increased risk of mortality, ...
Multiple myeloma patients have a fivefold increased risk of infections compared to healthy controls, with sepsis and pneumonia being the most prevalent. The study found a 70% infection risk in MM ...
January 13, 2009 — Tandem autologous hematopoietic cell transplantation (AHCT) does not appear to improve overall survival or event-free survival in patients with multiple myeloma, according to a meta ...
Multiple myeloma care shifts to four-drug frontline regimens and MRD testing, boosting deep responses and guiding relapse ...
Landmark decision by CHMP grants approval for self or caregiver administration for patients living with multiple myeloma1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results